安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

AMGN 安进

交易中 12-17 11:15:55 EST

328.43

+1.69

+0.52%

最高329.25	最低325.79	成交量45.96万
今开326.62	昨收326.74	日振幅1.06%
总市值1,769亿	流通市值1,764亿	总股本5.38亿
成交额1.51亿	换手率0.09%	流通股本5.37亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"AMGN","market":"US","secType":"STK","nameCN":"安进","latestPrice":328.43,"timestamp":1765988153980,"preClose":326.74,"halted":0,"volume":459598,"delay":0,"floatShares":536994627,"shares":538480671,"eps":12.933825,"marketStatus":"交易中","change":1.69,"latestTime":"12-17 11:15:55 EST","open":326.62,"high":329.25,"low":325.79,"amount":150699058.93359998,"amplitude":0.010589,"askPrice":328.53,"askSize":180,"bidPrice":328.37,"bidSize":10,"shortable":3,"etf":0,"ttmEps":12.933825,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1766005200000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":423288000000,"exchange":"NASDAQ","adjPreClose":326.74,"dividendRate":0.028591,"preHourTrading":{"tag":"盘前","latestPrice":327.53,"preClose":326.74,"latestTime":"09:29 EST","volume":13730,"amount":4488325.1921999995,"timestamp":1765981799999},"postHourTrading":{"tag":"盘后","latestPrice":326.54,"preClose":326.74,"latestTime":"19:58 EST","volume":206553,"amount":67488483.135,"timestamp":1765933118423},"volumeRatio":0.58447,"impliedVol":0.2471,"impliedVolPercentile":0.212},"requestUrl":"/m/hq/s/AMGN","defaultTab":"news","newsList":[{"id":"2590658555","title":"富国银行上调安进目标价至325美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2590658555","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590658555?lang=zh_cn&edition=full","pubTime":"2025-12-11 11:10","pubTimestamp":1765422640,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1983299246.USD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","BK4581","LU0289739699.SGD","LU0058720904.USD","BK4139","LU2242652126.USD","BK4566","LU2242646821.SGD","LU2089984988.USD","LU2468319806.SGD","LU0122379950.USD","LU1571399168.USD","LU0109394709.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1057294990.SGD","AMGN","LU0868494617.USD","BK4534","LU0320765992.SGD","LU2112291526.USD","BK4588","BK4599","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","IE00BFTCPJ56.SGD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2588097930","title":"BMO?Capital上调安进目标价至372美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2588097930","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588097930?lang=zh_cn&edition=full","pubTime":"2025-12-04 15:47","pubTimestamp":1764834421,"startTime":"0","endTime":"0","summary":"BMO Capital将安进的目标价从335美元上调至372美元，维持“跑赢大盘”评级。(格隆汇)","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20251204/31844270.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BMO","AMGN"],"gpt_icon":0},{"id":"1142961402","title":"这些美股股票今年表现优于大盘，并且明年估值依然便宜","url":"https://stock-news.laohu8.com/highlight/detail?id=1142961402","media":"老虎资讯综合","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142961402?lang=zh_cn&edition=full","pubTime":"2025-11-28 11:25","pubTimestamp":1764300339,"startTime":"0","endTime":"0","summary":"今年有不少公司股价大涨、深受分析师喜爱，但对投资者来说它们依然是有值得买入的机会。美国主要股指今年表现亮眼，主要受益于与人工智能交易相关的股票持续受到资金追捧。标普500指数今年上涨近16%，而由30只成分股组成的道琼斯工业平均指数上涨了11.5%。其中特别筛选标普500成分股中那些跑赢大盘、但其未来市盈率低于标普平均水平的股票，显示它们依然便宜、仍有上升空间。","market":"us","thumbnail":"https://community-static.tradeup.com/news/6eb4836c66fcd280682ed7e363fb2822","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/6eb4836c66fcd280682ed7e363fb2822"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"590c69c37c3ebb336a46696d7929f68d","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"这些股票今年表现优于大盘，并且明年依然估值便宜","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MDT","VST","AMGN","CVS","ABBV","NEM","CSCO"],"gpt_icon":1},{"id":"1141314391","title":"Immunoscape与Cue Biopharma达成许可协议 开发新型疗法以攻克实体肿瘤癌症","url":"https://stock-news.laohu8.com/highlight/detail?id=1141314391","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1141314391?lang=zh_cn&edition=full","pubTime":"2025-11-14 02:16","pubTimestamp":1763057789,"startTime":"0","endTime":"0","summary":"Immunoscape与Cue Biopharma达成许可协议，旨在开发新型疗法以攻击实体肿瘤癌症。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","BK4566","BK4533","IE00B2B36J28.USD","IE0002141913.USD","LU1061106388.HKD","LU0868494617.USD","BK4585","LU2242652126.USD","SG9999001440.SGD","BK4139","LU2089984988.USD","LU1023059063.AUD","IE00BJT1NW94.SGD","CUE","LU1571399168.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU0122379950.USD","AMGN","IE00BJJMRZ35.SGD","LU2242646821.SGD","BK4599","LU0889565916.HKD","BK4581","LU0109394709.USD","LU1057294990.SGD","IE0009355771.USD","BK4534","BK4588","LU2112291526.USD","LU2468319806.SGD","LU1983299246.USD"],"gpt_icon":0},{"id":"2582808827","title":"安进瑞百安®证明初级预防获益","url":"https://stock-news.laohu8.com/highlight/detail?id=2582808827","media":"环球市场播报","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582808827?lang=zh_cn&edition=full","pubTime":"2025-11-10 23:18","pubTimestamp":1762787880,"startTime":"0","endTime":"0","summary":"美股周一早盘，安进（AMGN）股价上涨0.9%，此前该公司报告VESALIUS-CV研究显示，其药物瑞百安®（Repatha®，通用名依洛尤单抗注射液）使无既往事件的高危患者首发主要心血管事件减少25%，首发心肌梗死减少36，这支持了PCSK9抑制剂的更广泛应用。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-11-10/doc-infwxxhn2537078.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0289739699.SGD","LU2242646821.SGD","IE00B2B36J28.USD","SG9999001440.SGD","BK4533","IE00BJT1NW94.SGD","BK4534","BK4585","LU2242652126.USD","LU1571399168.USD","BK4566","BK4588","LU0889565916.HKD","IE0009355771.USD","LU1983299246.USD","LU2112291526.USD","AMGN","BK4581","BK4599","LU0058720904.USD","BK4139","LU1023059063.AUD","LU2089984988.USD","LU0320765992.SGD","LU2468319806.SGD","LU0109394709.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"1170256770","title":"安进：Repatha在第三阶段Vesalius-Cv试验中将首次重大不良心血管事件风险降低25%","url":"https://stock-news.laohu8.com/highlight/detail?id=1170256770","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170256770?lang=zh_cn&edition=full","pubTime":"2025-11-08 23:10","pubTimestamp":1762614616,"startTime":"0","endTime":"0","summary":"安进：Repatha在第三阶段Vesalius-Cv试验中将首次重大不良心血管事件风险降低25%","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B2B36J28.USD","LU1023059063.AUD","LU1061106388.HKD","LU2242646821.SGD","BK4139","LU0868494617.USD","LU0109394709.USD","LU2468319806.SGD","LU0122379950.USD","BK4581","LU2112291526.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4588","LU2089984988.USD","AMGN","LU1571399168.USD","BK4534","BK4566","IE00BFTCPJ56.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LU1983299246.USD","LU0289739699.SGD","LU0320765992.SGD","LU2242652126.USD","LU0889565916.HKD","BK4533","SG9999001440.SGD","BK4599","LU1057294990.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"2581890628","title":"外高桥集团与安进达成战略合作 助力保税区域持续强化生物医药产业集群标杆地位","url":"https://stock-news.laohu8.com/highlight/detail?id=2581890628","media":"外高桥之窗","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581890628?lang=zh_cn&edition=full","pubTime":"2025-11-07 17:51","pubTimestamp":1762509096,"startTime":"0","endTime":"0","summary":"11月6日，在第八届进博会现场，上海外高桥集团股份有限公司与安进生物医药（上海）有限公司签署战略合作备忘录。双方将在通关便利化及保税物流等领域深化合作，构建“战略协同、互利共赢”的新范式，助力外高桥持续强化生物医药产业集群标杆地位，同时巩固安进在华发展的坚实基础。此次合作的达成将进一步巩固安进在中国发展的基础，助力保税区域持续强化生物医药产业集群标杆地位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107214629a4906fb4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107214629a4906fb4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0058720904.USD","LU0889565916.HKD","BK4139","LU1057294990.SGD","LU1023059063.AUD","IE00BJT1NW94.SGD","BK4588","IE00B2B36J28.USD","LU0868494617.USD","LU0289739699.SGD","IE0009355771.USD","LU1061106388.HKD","LU2112291526.USD","LU2468319806.SGD","BK4581","SG9999001440.SGD","LU2242652126.USD","BK4533","IE00B4R5TH58.HKD","LU2089984988.USD","AMGN","BK4599","LU0109394709.USD","LU2242646821.SGD","LU1571399168.USD","IE00BJJMRZ35.SGD","LU1983299246.USD","LU0122379950.USD","IE0002141913.USD","BK4566","LU0320765992.SGD","BK4534","IE00BFTCPJ56.SGD","BK4585"],"gpt_icon":0},{"id":"2581890638","title":"安进与中国心血管健康研究院启动战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2581890638","media":"中国网财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581890638?lang=zh_cn&edition=full","pubTime":"2025-11-07 15:20","pubTimestamp":1762500023,"startTime":"0","endTime":"0","summary":"中国网财经11月7日讯昨日在第八届中国国际进口博览会上，安进与中国心血管健康研究院正式启动战略合作，支持其推动中国心血管健康事业高质量发展，加速中国心血管事件拐点早日到来。据了解，近年来安进支持联盟开展多项创新项目，涵盖血脂管理优化、临床路径规范与胸痛中心建设等，持续赋能患者全程管理与疾病预防体系完善。降低LDL-C水平可显著减少ASCVD发病及死亡危险。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107152614a48f7ef6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251107152614a48f7ef6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BFTCPJ56.SGD","IE0002141913.USD","IE00B4R5TH58.HKD","LU1057294990.SGD","LU0289739699.SGD","LU2242646821.SGD","IE00B2B36J28.USD","SG9999001440.SGD","BK4533","IE00BJT1NW94.SGD","BK4534","BK4585","LU2242652126.USD","LU1571399168.USD","BK4566","BK4588","LU0889565916.HKD","IE0009355771.USD","LU1983299246.USD","LU2112291526.USD","AMGN","BK4581","BK4599","LU0058720904.USD","BK4139","LU1023059063.AUD","LU2089984988.USD","LU0320765992.SGD","LU2468319806.SGD","LU0109394709.USD","LU0868494617.USD","IE00BJJMRZ35.SGD","LU0122379950.USD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2581024888","title":"安进与外高桥集团签署战略合作协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2581024888","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581024888?lang=zh_cn&edition=full","pubTime":"2025-11-07 11:50","pubTimestamp":1762487430,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU1061106388.HKD","BK4581","LU2242652126.USD","BK4566","IE00BJT1NW94.SGD","BK0188","LU0320765992.SGD","LU0889565916.HKD","BK4139","LU1057294990.SGD","LU1983299246.USD","IE0009355771.USD","LU2112291526.USD","BK0012","AMGN","BK0250","BK0028","BK4585","BK0053","LU2089984988.USD","BK0011","BK0184","LU0868494617.USD","LU1571399168.USD","BK4599","LU0122379950.USD","IE00BFTCPJ56.SGD","SG9999001440.SGD","LU2468319806.SGD","LU0289739699.SGD","LU0058720904.USD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4588","BK0020","IE0002141913.USD","600648","IE00BJJMRZ35.SGD","IE00B2B36J28.USD","LU2242646821.SGD","BK4534","LU1023059063.AUD","BK4533"],"gpt_icon":0},{"id":"2581944767","title":"再鼎医药(09688)：关于安进公司贝玛妥珠单抗 1b/3期临床研究FORTITUDE-102的更新","url":"https://stock-news.laohu8.com/highlight/detail?id=2581944767","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581944767?lang=zh_cn&edition=full","pubTime":"2025-11-05 08:04","pubTimestamp":1762301064,"startTime":"0","endTime":"0","summary":"智通财经APP讯，再鼎医药(09688)发布公告，公司的合作伙伴及该研究申办方安进公司，于2025年11月4日在其2025年第三季度财报发布会期间宣布，评估贝玛妥珠单抗联合化疗及纳武利尤单抗用于一线胃癌的 1b/3 期临床研究FORTITUDE-102，由于根据资料监查委员会的要求所做的临时分析显示疗效不足已停止。更多港股重磅资讯，下载智通财经app更多港股及海外理财资讯，请点击www.zhitongcaijing.com（搜索“智通财经”）；欲加入智通港股投资群，请加智通客服微信(ztcjkf)","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1365318.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK4548","LU2488822045.USD","LU2112291526.USD","BK1574","LU1023059063.AUD","LU0122379950.USD","BK4531","BK1161","BK4585","LU0889565916.HKD","LU1983299246.USD","LU1057294990.SGD","IE00B2B36J28.USD","LU0868494617.USD","IE0002141913.USD","LU2242646821.SGD","BK4599","LU2468319806.SGD","AMGN","BK1588","BK4533","LU2242652126.USD","LU0058720904.USD","BK4534","IE00BFTCPJ56.SGD","LU0109394709.USD","LU2089984988.USD","ZLAB","BK4581","LU1061106388.HKD","IE00BJJMRZ35.SGD","LU1571399168.USD","LU0320765992.SGD","09688","BK4139","IE0009355771.USD","SG9999001440.SGD","IE00B4R5TH58.HKD","BK4526","BK4588","IE00BJT1NW94.SGD","LU0289739699.SGD","BK4566"],"gpt_icon":0},{"id":"1129493398","title":"安进标志性III期Repatha数据将在2025年美国心脏协会科学会议上作为热点新闻发布","url":"https://stock-news.laohu8.com/highlight/detail?id=1129493398","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129493398?lang=zh_cn&edition=full","pubTime":"2025-10-31 21:00","pubTimestamp":1761915616,"startTime":"0","endTime":"0","summary":"安进标志性III期Repatha数据将在2025年美国心脏协会科学会议上作为热点新闻发布","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4581","IE00BJT1NW94.SGD","LU0058720904.USD","LU1983299246.USD","BK4599","LU1023059063.AUD","LU0868494617.USD","BK4566","AMGN","IE00BJJMRZ35.SGD","SG9999001440.SGD","IE0009355771.USD","LU1061106388.HKD","LU2468319806.SGD","LU1571399168.USD","BK4585","IE0002141913.USD","BK4533","LU2242646821.SGD","LU0289739699.SGD","LU0122379950.USD","BK4139","LU0109394709.USD","BK4588","BK4534","LU0889565916.HKD","LU1057294990.SGD","LU2089984988.USD","LU2242652126.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","LU2112291526.USD","IE00B2B36J28.USD"],"gpt_icon":0},{"id":"1117083876","title":"恩多推出美国首个也是唯一的Ravicti®（甘油苯丁酸酯）口服液的仿制药","url":"https://stock-news.laohu8.com/highlight/detail?id=1117083876","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1117083876?lang=zh_cn&edition=full","pubTime":"2025-10-20 19:33","pubTimestamp":1760959996,"startTime":"0","endTime":"0","summary":"恩多推出美国首个也是唯一的Ravicti®（甘油苯丁酸酯）口服液的仿制药","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","IE00B2B36J28.USD","LU1023059063.AUD","LU1061106388.HKD","LU2242646821.SGD","BK4139","LU0868494617.USD","LU0109394709.USD","LU2468319806.SGD","LU0122379950.USD","BK4581","LU2112291526.USD","IE00B4R5TH58.HKD","IE00BJJMRZ35.SGD","BK4588","LU2089984988.USD","AMGN","LU1571399168.USD","BK4534","BK4566","IE00BFTCPJ56.SGD","LU0058720904.USD","IE00BJT1NW94.SGD","IE0002141913.USD","LU1983299246.USD","LU0289739699.SGD","LU0320765992.SGD","LU2242652126.USD","LU0889565916.HKD","BK4533","SG9999001440.SGD","BK4599","LU1057294990.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"1106155676","title":"安进：贝马替珠单抗（Bema）在Fortitude-101 III期临床试验的初步分析中显示出统计学显著的生存获益","url":"https://stock-news.laohu8.com/highlight/detail?id=1106155676","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1106155676?lang=zh_cn&edition=full","pubTime":"2025-10-20 06:05","pubTimestamp":1760911511,"startTime":"0","endTime":"0","summary":"安进：贝马替珠单抗（Bema）在Fortitude-101 III期临床试验的初步分析中显示出统计学显著的生存获益。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2468319806.SGD","LU2089984988.USD","BK4533","BK4566","LU1983299246.USD","LU0109394709.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU0868494617.USD","LU0122379950.USD","BK4534","IE00B4R5TH58.HKD","LU1571399168.USD","IE00B2B36J28.USD","SG9999001440.SGD","BK4585","LU1057294990.SGD","BK4581","LU0889565916.HKD","LU1023059063.AUD","BK4588","LU2242652126.USD","AMGN","LU2242646821.SGD","LU2112291526.USD","LU1061106388.HKD","BK4139","IE0002141913.USD","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","IE00BJJMRZ35.SGD","BK4599"],"gpt_icon":0},{"id":"2576825878","title":"ESMO大会本周重磅开幕；超 4款国产新药出海，翰森、奥赛康、维立志博科伦 ADC新药获批上市 Insight新药周报","url":"https://stock-news.laohu8.com/highlight/detail?id=2576825878","media":"动脉网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576825878?lang=zh_cn&edition=full","pubTime":"2025-10-19 20:05","pubTimestamp":1760875500,"startTime":"0","endTime":"0","summary":"ESMO大会本周开幕，据Insight数据库统计，10月12日至18日，全球86款创新药研发有新进展，其中1款获批上市，5款申报上市，2款首次启动III期临床，19款启动临床，26款申报临床。境外部分，本周23款药物研发有推进，包括1款首次启动III期临床，9款首次启动临床，8款首次获批临床。此外，诺华公布了伊普可泮Ⅲ期最终分析结果。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102001380797372ce2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025102001380797372ce2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1983299246.USD","IE0002141913.USD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","BK4581","LU0289739699.SGD","LU0058720904.USD","BK4231","BK4139","LU2242652126.USD","BK4080","BK4566","LU2242646821.SGD","LU2089984988.USD","LU2468319806.SGD","LU0122379950.USD","LU1571399168.USD","LU0109394709.USD","SG9999001440.SGD","IE00BJT1NW94.SGD","LU1023059063.AUD","IE00BJJMRZ35.SGD","LU1057294990.SGD","AMGN","LU0868494617.USD","BK4534","LU0320765992.SGD","LU2112291526.USD","INAQU","BK4588","BK4599","LU0889565916.HKD","IE00B4R5TH58.HKD","BK4533","ADC","IE00BFTCPJ56.SGD","LU1061106388.HKD"],"gpt_icon":0},{"id":"2576570703","title":"安进涨0.90% 股价突破300美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2576570703","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576570703?lang=zh_cn&edition=full","pubTime":"2025-10-16 21:57","pubTimestamp":1760623026,"startTime":"0","endTime":"0","summary":"北京时间2025年10月16日21时57分，安进股票出现异动，股价急速拉升0.90%。截至发稿，该股报300.00美元/股，成交量11.2623万股，换手率0.02%，振幅0.81%。安进股票所在的制药行业中，整体涨幅为0.63%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。公司2023年收购Horizon带来了多种罕见疾病药物，包括甲状腺眼病药物Tepezza。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016215706a6bd2908&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251016215706a6bd2908&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1023059063.AUD","BK4585","LU1061106388.HKD","IE00BJT1NW94.SGD","BK4534","BK4533","LU0868494617.USD","BK4588","BK4139","SG9999001440.SGD","LU2242646821.SGD","LU0109394709.USD","LU0289739699.SGD","LU0122379950.USD","LU2089984988.USD","LU0889565916.HKD","IE00BFTCPJ56.SGD","BK4599","LU0058720904.USD","BK4566","LU2242652126.USD","LU1983299246.USD","IE00B4R5TH58.HKD","AMGN","LU0320765992.SGD","LU2468319806.SGD","LU1057294990.SGD","LU1571399168.USD","IE00B2B36J28.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE0002141913.USD","LU2112291526.USD","BK4581"],"gpt_icon":0},{"id":"2573883958","title":"安进胆固醇药物在美国降价60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2573883958","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2573883958?lang=zh_cn&edition=full","pubTime":"2025-10-07 15:48","pubTimestamp":1759823333,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["BK4581","LU0868494617.USD","IE00BFTCPJ56.SGD","BK4585","LU2468319806.SGD","IE00BJT1NW94.SGD","BK4139","BK4599","IE00B2B36J28.USD","LU1571399168.USD","IE00B4R5TH58.HKD","LU0289739699.SGD","SG9999001440.SGD","LU0889565916.HKD","LU2089984988.USD","LU2242646821.SGD","IE00BJJMRZ35.SGD","LU1057294990.SGD","BK4533","BK4534","IE0002141913.USD","BK4588","LU1023059063.AUD","LU0058720904.USD","LU0320765992.SGD","AMGN","LU1983299246.USD","LU2112291526.USD","LU1061106388.HKD","IE0009355771.USD","LU2242652126.USD","LU0122379950.USD","LU0109394709.USD","BK4566"],"gpt_icon":0},{"id":"1181136672","title":"安进：患者援助项目面向全体患者开放，涵盖无保险、高免赔额计划及现金支付患者","url":"https://stock-news.laohu8.com/highlight/detail?id=1181136672","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181136672?lang=zh_cn&edition=full","pubTime":"2025-10-06 21:01","pubTimestamp":1759755687,"startTime":"0","endTime":"0","summary":"安进(Amgen)宣布，其患者援助项目向所有患者群体开放，覆盖范围包括无医疗保险患者、参与高免赔额健康保险计划的患者，以及选择现金或自费支付的患者。该项目旨在为更广泛的患者群体提供药物可及性支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AMGN","IE0002141913.USD","LU0122379950.USD","LU1057294990.SGD","IE00BFTCPJ56.SGD","LU1571399168.USD","IE00BJT1NW94.SGD","IE0009355771.USD","LU1061106388.HKD","LU2242646821.SGD","SG9999001440.SGD","IE00B2B36J28.USD","BK4599","LU1983299246.USD","BK4533","LU0889565916.HKD","IE00B4R5TH58.HKD","LU2089984988.USD","BK4581","LU0868494617.USD","BK4588","LU0320765992.SGD","LU2242652126.USD","LU1023059063.AUD","LU0289739699.SGD","BK4585","BK4139","LU0109394709.USD","LU2112291526.USD","BK4534","IE00BJJMRZ35.SGD","BK4566","LU2468319806.SGD","LU0058720904.USD"],"gpt_icon":0},{"id":"1121063765","title":"里程碑式3期临床试验Vesalius-Cv在涉及12,000名患者的心血管初级预防研究中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1121063765","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1121063765?lang=zh_cn&edition=full","pubTime":"2025-10-02 21:02","pubTimestamp":1759410154,"startTime":"0","endTime":"0","summary":"里程碑式3期临床试验Vesalius-Cv在涉及12,000名患者的心血管初级预防研究中成功达到主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4599","LU0320765992.SGD","LU2242646821.SGD","AMGN","BK4533","LU0889565916.HKD","LU1023059063.AUD","LU1057294990.SGD","LU2112291526.USD","IE00B2B36J28.USD","BK4588","LU1983299246.USD","IE0002141913.USD","IE0009355771.USD","LU2089984988.USD","BK4139","LU0122379950.USD","LU2242652126.USD","IE00BJT1NW94.SGD","LU0868494617.USD","LU0058720904.USD","IE00BFTCPJ56.SGD","LU2468319806.SGD","BK4585","IE00BJJMRZ35.SGD","LU1061106388.HKD","BK4581","BK4566","LU0289739699.SGD","SG9999001440.SGD","IE00B4R5TH58.HKD","LU0109394709.USD","LU1571399168.USD","BK4534"],"gpt_icon":0},{"id":"2572371902","title":"安进盘中异动 急速拉升3.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2572371902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2572371902?lang=zh_cn&edition=full","pubTime":"2025-10-01 00:40","pubTimestamp":1759250426,"startTime":"0","endTime":"0","summary":"北京时间2025年10月01日00时40分，安进股票出现异动，股价急速上涨3.04%。截至发稿，该股报282.29美元/股，成交量140.401万股，换手率0.26%，振幅2.93%。机构评级方面，在所有33家参与评级的机构中，42%的券商给予买入建议，48%的券商给予持有建议，10%的券商给予卖出建议。安进股票所在的制药行业中，整体涨幅为2.06%。安进于 2006 年推出了首款癌症治疗药物 Vectibix，并销售骨强化药物 Prolia/Xgeva和 Evenity。同时，安进还拥有不断增长的生物仿制药产品组合。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001004026a44eec80&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251001004026a44eec80&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00BJJMRZ35.SGD","LU2112291526.USD","LU0289739699.SGD","BK4585","LU0122379950.USD","SG9999001440.SGD","IE0009355771.USD","LU0109394709.USD","BK4534","BK4588","BK4139","LU2242652126.USD","LU1057294990.SGD","BK4599","LU0058720904.USD","IE00BJT1NW94.SGD","BK4581","LU1571399168.USD","IE00B2B36J28.USD","LU1061106388.HKD","LU1023059063.AUD","LU1983299246.USD","BK4533","IE0002141913.USD","BK4566","LU0320765992.SGD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","LU2089984988.USD","AMGN","LU2242646821.SGD","LU2468319806.SGD","LU0868494617.USD","LU0889565916.HKD"],"gpt_icon":0},{"id":"2570059835","title":"花旗上调安进目标价至315美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2570059835","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570059835?lang=zh_cn&edition=full","pubTime":"2025-09-25 11:05","pubTimestamp":1758769541,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["LU0052756011.USD","LU1668664300.SGD","LU2456880835.USD","BK4207","LU1162221912.USD","BK4581","LU2125154935.USD","BK4533","IE00B2B36J28.USD","LU0289739699.SGD","LU2112291526.USD","LU0072461881.USD","LU0320765992.SGD","LU1057294990.SGD","BK4599","IE00B4R5TH58.HKD","LU0109394709.USD","LU1267930227.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","LU1201861249.SGD","IE00BFTCPJ56.SGD","LU2242646821.SGD","LU0122379950.USD","LU1244550494.USD","LU0130102774.USD","IE0002141913.USD","AMGN","LU2089984988.USD","BK4585","LU0130517989.USD","LU0320765646.SGD","BK4504","LU0648001328.SGD","LU0128525689.USD","LU1791807156.HKD","BK4566","LU0889565916.HKD","LU1061106388.HKD","LU0170899867.USD","LU1571399168.USD","LU1983299246.USD","LU2242652126.USD","LU0106831901.USD","SG9999001440.SGD","LU1244550221.USD","IE00BJJMRZ35.SGD","BK4559","BK4534","LU2125154778.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.amgen.com","stockEarnings":[{"period":"1week","weight":0.0411},{"period":"1month","weight":-0.0297},{"period":"3month","weight":0.1894},{"period":"6month","weight":0.1281},{"period":"1year","weight":0.226},{"period":"ytd","weight":0.2536}],"compareEarnings":[{"period":"1week","weight":-0.0061},{"period":"1month","weight":0.0103},{"period":"3month","weight":0.0299},{"period":"6month","weight":0.1363},{"period":"1year","weight":0.1188},{"period":"ytd","weight":0.1583}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Amgen Inc是一家生物技术公司。该公司从事发现、开发、生产和提供治疗最棘手疾病的药物。该公司专注于医疗需求尚未得到满足的领域，并利用专业知识努力寻求改善人们生活的解决方案。该公司在人类治疗领域开展业务。该公司的营销产品组合包括EPOGEN（阿法依泊汀）、Aranesp（阿法达贝泊汀）、Parsabiv（etelcalcetide）、Neulasta（培非格司亭）；KANJINTI（曲妥珠单抗）、Otezla、BLINCYTO（blinatumomab）、ACTIMMUNE（干扰素γ-1b）、Neulasta（培非格司亭）、Sensipar/Mimpara（西那卡塞）、Prolia（地舒单抗）、ENBREL、QUINSAIR（左氧氟沙星）、Repatha（依洛尤单抗）等。该公司在美国和加拿大销售肿瘤坏死因子阻断剂ENBREL。该公司在全球许多国家销售抑制磷酸二酯酶4的小分子药物Otezla。该公司在全球许多国家销售前蛋白转化酶枯草溶菌素/kexin 9型 (PCSK9) 抑制剂Repatha。","yearOnYearQuotes":[{"month":1,"riseRate":0.642857,"avgChangeRate":0.034093},{"month":2,"riseRate":0.47619,"avgChangeRate":-0.001155},{"month":3,"riseRate":0.52381,"avgChangeRate":0.019224},{"month":4,"riseRate":0.452381,"avgChangeRate":-0.002852},{"month":5,"riseRate":0.52381,"avgChangeRate":0.024179},{"month":6,"riseRate":0.5,"avgChangeRate":0.003875},{"month":7,"riseRate":0.767442,"avgChangeRate":0.052562},{"month":8,"riseRate":0.604651,"avgChangeRate":0.004451},{"month":9,"riseRate":0.511628,"avgChangeRate":0.002296},{"month":10,"riseRate":0.534884,"avgChangeRate":0.021538},{"month":11,"riseRate":0.627907,"avgChangeRate":0.022348},{"month":12,"riseRate":0.627907,"avgChangeRate":0.045407}],"exchange":"NASDAQ","name":"安进","nameEN":"Amgen"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"安进,AMGN,安进股票,安进股票老虎,安进股票老虎国际,安进行情,安进股票行情,安进股价,安进股市,安进股票价格,安进股票交易,安进股票购买,安进股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"安进(AMGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供安进(AMGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}